147 related articles for article (PubMed ID: 35143913)
1. Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study.
Morgan FC; Yehia L; McDonald C; Martinez-Agosto JA; Hardan AY; Tamburro J; Sahin M; Bayart C; Eng C;
J Am Acad Dermatol; 2023 Jul; 89(1):90-98. PubMed ID: 35143913
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract][Full Text] [Related]
4. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
5. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
[TBL] [Abstract][Full Text] [Related]
6. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
[TBL] [Abstract][Full Text] [Related]
7. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
[TBL] [Abstract][Full Text] [Related]
8. Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect--PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome.
Nosé V
Head Neck Pathol; 2016 Jun; 10(2):131-8. PubMed ID: 26975628
[TBL] [Abstract][Full Text] [Related]
9. The PTEN hamartoma tumor syndrome: how oral clinicians may save lives.
Fardal Ø; Nevland K; Johannessen AC; Vetti HH
Clin Adv Periodontics; 2023 Mar; 13(1):21-26. PubMed ID: 35352876
[TBL] [Abstract][Full Text] [Related]
10. Chiari I malformation in a child with PTEN hamartoma tumor syndrome: Association or coincidence?
Saletti V; Esposito S; Maccaro A; Giglio S; Valentini LG; Chiapparini L
Eur J Med Genet; 2017 May; 60(5):261-264. PubMed ID: 28286253
[TBL] [Abstract][Full Text] [Related]
11. Arteriovenous malformations as a presenting sign of PTEN hamartoma tumor syndrome: A case series.
Dykman M; Pillai NR; Lenhart K; Nicholson C; Boull C; Fritz E; Flanagan S; Maguiness S
Pediatr Dermatol; 2024; 41(2):292-295. PubMed ID: 37800459
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome.
Martin H; Bessis D; Bourrat E; Mazereeuw-Hautier J; Morice-Picard F; Balguerie X; Chiaverini C;
Pediatr Dermatol; 2020 Sep; 37(5):839-843. PubMed ID: 32657433
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.
Henderson CJ; Ngeow J; Collins MH; Martin LJ; Putnam PE; Abonia JP; Marsolo K; Eng C; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):553-60. PubMed ID: 24345843
[TBL] [Abstract][Full Text] [Related]
14.
Schultz KAP; Rednam SP; Kamihara J; Doros L; Achatz MI; Wasserman JD; Diller LR; Brugières L; Druker H; Schneider KA; McGee RB; Foulkes WD
Clin Cancer Res; 2017 Jun; 23(12):e76-e82. PubMed ID: 28620008
[No Abstract] [Full Text] [Related]
15. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
[TBL] [Abstract][Full Text] [Related]
16. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
[TBL] [Abstract][Full Text] [Related]
17. Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review.
Milani D; Dolci A; Muller I; Pavesi MA; Runza L; Kuhn E; Natacci F; Peissel B; Ricci MT; Despini L; Tomasello G; Grossi F; Garrone O; Gambini D
Endocrine; 2023 Jul; 81(1):98-106. PubMed ID: 36690897
[TBL] [Abstract][Full Text] [Related]
18. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.
Kurek KC; Howard E; Tennant LB; Upton J; Alomari AI; Burrows PE; Chalache K; Harris DJ; Trenor CC; Eng C; Fishman SJ; Mulliken JB; Perez-Atayde AR; Kozakewich HP
Am J Surg Pathol; 2012 May; 36(5):671-87. PubMed ID: 22446940
[TBL] [Abstract][Full Text] [Related]
19. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
Mester JL; Zhou M; Prescott N; Eng C
Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
[TBL] [Abstract][Full Text] [Related]
20. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
